Gilder Gagnon Howe & Co. LLC Sells 80,114 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Gilder Gagnon Howe & Co. LLC cut its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 7.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,041,736 shares of the company's stock after selling 80,114 shares during the quarter. Gilder Gagnon Howe & Co. LLC owned about 0.61% of Option Care Health worth $24,168,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of the company. Barclays PLC increased its holdings in shares of Option Care Health by 180.1% in the 3rd quarter. Barclays PLC now owns 310,194 shares of the company's stock valued at $9,708,000 after acquiring an additional 199,454 shares during the last quarter. Central Pacific Bank Trust Division raised its position in Option Care Health by 6.9% during the 4th quarter. Central Pacific Bank Trust Division now owns 10,079 shares of the company's stock worth $234,000 after buying an additional 650 shares during the last quarter. Nordea Investment Management AB raised its position in Option Care Health by 6.0% during the 4th quarter. Nordea Investment Management AB now owns 94,641 shares of the company's stock worth $2,165,000 after buying an additional 5,365 shares during the last quarter. Harbor Capital Advisors Inc. increased its holdings in shares of Option Care Health by 2.7% in the 4th quarter. Harbor Capital Advisors Inc. now owns 213,155 shares of the company's stock valued at $4,945,000 after purchasing an additional 5,595 shares in the last quarter. Finally, Graypoint LLC purchased a new position in shares of Option Care Health in the 4th quarter valued at about $1,161,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Insiders Place Their Bets

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.64% of the company's stock.

Option Care Health Stock Performance

NASDAQ:OPCH traded down $2.28 during mid-day trading on Tuesday, hitting $30.69. 6,223,955 shares of the company's stock traded hands, compared to its average volume of 1,799,880. The firm has a 50 day moving average of $33.37 and a two-hundred day moving average of $28.78. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $5.04 billion, a price-to-earnings ratio of 25.79, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53.

Analysts Set New Price Targets

OPCH has been the subject of a number of recent research reports. Barrington Research reiterated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a report on Monday, April 21st. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a research report on Tuesday, April 22nd. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and increased their price objective for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $33.75.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.